Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy
Cannabis Investing Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology
Pharmaceutical Investing Merck Announces Appointment of Cristal N. Downing as Chief Communications & Public Affairs Officer
Medical Device Investing Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney
Medical Device Investing New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations
Medical Device Investing First Gynecological Procedures Performed with Medtronic Hugo Robotic-Assisted Surgery System
FDA Approves Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
